S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Public Service Announcement: New National Emergency Incoming (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Public Service Announcement: New National Emergency Incoming (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Public Service Announcement: New National Emergency Incoming (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Public Service Announcement: New National Emergency Incoming (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
OTCMKTS:WUXIF

WuXi AppTec (WUXIF) Stock Forecast, Price & News

$10.70
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$10.70
$10.70
50-Day Range
$8.61
$10.70
52-Week Range
$7.91
$12.41
Volume
N/A
Average Volume
250 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

WUXIF stock logo

About WuXi AppTec (OTCMKTS:WUXIF) Stock

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

WUXIF Price History

WUXIF Stock News Headlines

WUXI APPTEC H 02359 YC1 (WX8.DU)
These cryptos could skyrocket by January
After the massive market collapse and several huge scandals last year, a lot of experts are saying the crypto markets are just one more step away from going to zero. But are they right?
These cryptos could skyrocket by January
After the massive market collapse and several huge scandals last year, a lot of experts are saying the crypto markets are just one more step away from going to zero. But are they right?
WX8.SG - Wuxi AppTec Co Ltd
WuXi AppTec's First-Quarter Profit Surges
See More Headlines
Receive WUXIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:WUXIF
CIK
N/A
Fax
N/A
Employees
41,296
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Ge Li Ph.D. (Age 56)
    Co-Founder, Chairman, Pres & CEO
    Comp: $5.75M
  • Dr. Minzhang Chen Ph.D. (Age 53)
    Co-CEO & Exec. Director
    Comp: $1.36M
  • Dr. Qing Yang Ph.D. (Age 53)
    Co-CEO & Exec. Director
    Comp: $1.17M
  • Dr. Edward Hu M.B.A. (Age 60)
    Vice Chairman & Global Chief Investment Officer
    Comp: $1.46M
  • Mr. Zhaohui Zhang (Age 53)
    COO of China, VP & Exec. Director
    Comp: $1.03M
  • Ms. Ming Shi (Age 48)
    Sr. VP & CFO
  • Mr. Kyler Lei
    IR Director
  • Dr. Howard Wu J.D.
    Sr. VP, Gen. Counsel & Global Head of HR
  • Dr. Shuhui Chen Ph.D. (Age 59)
    Exec. VP & Head of DDSU
  • Dr. Jingchao Dong Ph.D.
    Sr. VP & Head of RCS













WUXIF Stock - Frequently Asked Questions

How have WUXIF shares performed in 2023?

WuXi AppTec's stock was trading at $10.71 at the start of the year. Since then, WUXIF shares have decreased by 0.1% and is now trading at $10.70.
View the best growth stocks for 2023 here
.

Are investors shorting WuXi AppTec?

WuXi AppTec saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 603,600 shares, an increase of 23.9% from the August 31st total of 487,100 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 6,036.0 days.
View WuXi AppTec's Short Interest
.

What is WuXi AppTec's stock symbol?

WuXi AppTec trades on the OTCMKTS under the ticker symbol "WUXIF."

How do I buy shares of WuXi AppTec?

Shares of WUXIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is WuXi AppTec's stock price today?

One share of WUXIF stock can currently be purchased for approximately $10.70.

How many employees does WuXi AppTec have?

The company employs 41,296 workers across the globe.

How can I contact WuXi AppTec?

WuXi AppTec's mailing address is 288 Fute Middle Road, Shanghai, 200131. The official website for the company is www.wuxiapptec.com. The company can be reached via phone at 86-21-5046-1111.

This page (OTCMKTS:WUXIF) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -